ResearcherUniversité Côte d'AzurNo recent work listed

Jean GUGENHEIM MD3

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2624-3014; OpenAlex author ID A5042471747. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Neoadjuvant therapy for pancreatic cancer. Co-author DOI 10.1007/s13304-021-01186-1 ↗
Borderline resectable pancreatic cancer: an evolving concept. Co-author DOI 10.1093/annonc/mdx255 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Niccolò Petrucciani · 2 shared papers, 2017–2022 · strength 0.34
- Paper Neoadjuvant therapy for pancreatic cancer. DOI 10.1007/s13304-021-01186-1 ↗
- Paper Borderline resectable pancreatic cancer: an evolving concept. DOI 10.1093/annonc/mdx255 ↗
Giuseppe R. Nigri · 1 shared paper, 2017 · strength 0.08
- Paper Borderline resectable pancreatic cancer: an evolving concept. DOI 10.1093/annonc/mdx255 ↗
Giovanni Ramacciato · 1 shared paper, 2017 · strength 0.08
- Paper Borderline resectable pancreatic cancer: an evolving concept. DOI 10.1093/annonc/mdx255 ↗
Francesco D’Angelo · 1 shared paper, 2017 · strength 0.08
- Paper Borderline resectable pancreatic cancer: an evolving concept. DOI 10.1093/annonc/mdx255 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.